ABOUT
ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore.
ABOUT US
ClinActis is a leading full-service contract research organization (CRO) providing clinical trial services in the Asia Pacific region to pharmaceutical, medical device, medical nutrition, and biotech companies.
About
_2_edited.png)
Established in 2009 and headquartered in Singapore, ClinActis management and operational teams have more than 50 cumulative years of experience in clinical research.
We take pride in being one of the key players in clinical trials in Asia, and we are committed to providing high-quality and reliable services to our clients. Our experienced team of professionals has a deep understanding of the local cultures, regulations, and healthcare systems in the region, enabling us to deliver customized solutions that address the unique needs and specific requirements of each country in the region.
As a full-service CRO, we offer a comprehensive range of services and solutions, including study design, protocol development, site selection, project management, data management, biostatistics, medical writing, and regulatory affairs. Our goal is to provide our clients with a seamless and efficient clinical trial experience in Asia Pacific, from start to finish.
At ClinActis, we are dedicated to helping our clients bring safe and effective drugs and interventions to the market.
Experience
_2_edited.png)
50+ years
of cumulative experience in clinical research in pharmaceutical and biotechnology companies as well as CROs.
Experience in Asia Pacific: Australia,
New Zealand, China, Malaysia, Hong Kong, India, Indonesia, the Philippines, Singapore, South Korea, Taiwan, Thailand, Japan and Vietnam.
Extensive knowledge of local regulatory frameworks, best KOLs and highest-recruiting sites across the region.
Vast therapeutic experience in areas such as Oncology, Cardiovascular, Central Nervous System, Endocrinology, Infectious diseases, and Respiratory conditions.
Value Proposition
ClinActis is a premier clinical research organization (CRO) exclusively focused on delivering high-quality clinical research services in the Asia Pacific (APAC) region. Our unique value proposition is our team’s global clinical trial experience combined with its intimate knowledge of local sites, PIs, KOLs and regulatory systems across the region. This enables us to provide efficient and effective services in Asia that comply with international clinical trial quality standard for clients based anywhere in the world.
We believe that building a team with both global knowledge and local expertise is key to delivering high-quality clinical research services in the Asia Pacific region. Our team members have extensive experience working on regional and global, FDA/EMA-approved clinical trials, and are also experts in navigating the regulatory, operational, and cultural complexities of conducting clinical research across the APAC region.
By leveraging our expertise and experience, we can help you find the highest-recruiting, most quality-driven clinical sites for your study, ensuring that your trial remains on time, on budget, and conducted to the highest levels of quality and safety possible.
Quality
ClinActis is committed to implement international standards to clinical trials. Our ability to deliver high quality results to our clients is based on recruiting and maintaining the best talents within our organization. Our senior management is fully accountable for the quality of deliverables to our clients.
Cost Effective Solutions
ClinActis is able to provide fair and cost effective solutions to our clients. As a regional CRO, we have a streamlined but effective organization that minimizes overhead, enabling country-specific rates. These translate to savings in terms of cost for our clients. Moreover, our knowledge of the region allows us to provide realistic and reasonable budgets upfront to our clients and minimize subsequent budget changes during the study.